Obesity Featured Articles

  1. How To Capture Growth In The Expanding Metabolic Drug Market 12/2/2025

    Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.

  2. The Impact Of Expert PK/PD Modeling In Psychedelic Research 12/2/2025

    Model-informed development that integrates preclinical and literature-based data is enabling smarter predictions of exposure and safety, transforming psychedelic research and advancing clinical innovation.

  3. Need An Investigator? There's An APP — Advanced Practice Provider — For That 12/1/2025

    Fewer available principal investigators (PIs) is not a new problem for clinical research, but it does necessitate some new and creative solutions. Learn how advanced practice providers (APPs) might help fill the PI gap.

  4. Modern Data Platform Strategies That Accelerate Clinical Development 11/26/2025

    A modern data platform is essential for clinical research because it unifies fragmented data, embeds governance, and enables faster, more reliable decision-making.

  5. Digital Biomarkers Are Reshaping Alzheimer's Patient Experience And Data 11/26/2025

    Cognito CEO Christian Howell shares how EEG and digital biomarkers are reshaping recruitment, patient experience, and the quality of study data in Alzheimer’s research.

  6. An FDA First: Dompé Shares Experience Of Securing A Commissioner's National Priority Voucher 11/25/2025

    Dompé Chief Development Officer Ahmed Enayetallah reveals how the team earned the FDA's new Commissioner’s National Priority Voucher.

  7. ESMO Congress 2025: Highlights From Berlin 11/24/2025

    Turn the insights from this year’s ESMO into action by partnering to accelerate innovation through smarter trial design, stronger biomarker planning, and truly global collaboration.

  8. A Tale Of Two Sites: How FastWave Ran Trials In Distinct Locales 11/24/2025

    No two sites are the same. Discover how FastWave Medical chose its global sites, and learn best practices on who to partner with and how.

  9. Why Feasibility Still Feels Broken 11/24/2025

    During an interview with Dresden Whitehead of Avacare Clinical Research Network, her take on feasibility mirrored concerns raised during a 2024 Clinical Leader Live (CLL) webinar. She highlighted repetitive questionnaires, unclear sponsor expectations, and the challenges new investigators face. Combined with insights from the CLL discussion, the article explains why feasibility remains a persistent industry pain point.

  10. Why Site Relationships With Sponsors and CROs Must Evolve Now 11/24/2025

    Sites are central to drug development — we cannot run a trial without them — yet the industry continues to treat them as tactical, temporary instruments. It’s time to break this cycle, implores Jim Kremidas, executive director, Association of Multisite Research Corporations (AMRC).